MedPath

Andalusian Initiative for Advanced Therapies

🇪🇸Spain
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Intra-arterial Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke

Phase 2
Completed
Conditions
Ischemic Stroke
Interventions
Drug: Autologous bone marrow mononuclear cell intra-arterial injection
First Posted Date
2014-07-01
Last Posted Date
2024-02-07
Lead Sponsor
Andalusian Initiative for Advanced Therapies
Target Recruit Count
76
Registration Number
NCT02178657
Locations
🇪🇸

Hospital Universitario Puerta del Mar, Cadiz, Spain

🇪🇸

Hospital Universitario Reina Sofía, Córdoba, Spain

🇪🇸

Hospitales Universitarios Virgen del Rocio, Seville, Spain

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.